{"id":"W2561881161","doi":"10.1056/nejmoa1601277","title":"Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1961,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); McGill University; University of British Columbia","funders":"Agence Nationale de la Recherche","keywords":"Ocrelizumab; Medicine; Interferon beta-1a; Multiple sclerosis; Hazard ratio; Internal medicine; Confidence interval; Gastroenterology; Immunology; Interferon beta; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003368962,0.0006281267,0.00203468,0.0003800713,0.0002378418,0.0007543924,0.0005352767,0.001184741,0.002120121],"category_scores_gemma":[0.003801434,0.0003209803,0.001240517,0.0003370747,0.000651524,0.0006382357,0.0003778587,0.001628364,0.0003084039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007370123,"about_ca_system_score_gemma":0.0008049127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004627427,"about_ca_topic_score_gemma":0.0009856762,"domain_scores_codex":[0.998281,0.001175307,0.0001606439,0.0001568127,0.0001002002,0.0001260163],"domain_scores_gemma":[0.9971982,0.001434567,0.000638386,0.0001168339,0.0001107835,0.0005011635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9006403,0.002290709,0.002176426,0.000995743,0.0009916878,0.00009716265,0.00009715163,0.0007731002,0.002923499,0.0001791625,0.000598075,0.08823685],"study_design_scores_gemma":[0.7504543,0.2298837,0.01075043,0.000384673,0.001736017,0.000296715,0.00007878098,0.001572395,0.001673804,0.0005358525,0.002606679,0.00002667912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754706,0.02127745,0.0002463826,0.0009327927,0.0003986036,0.0003333022,0.0001137557,0.00003302651,0.001194089],"genre_scores_gemma":[0.9933391,0.004216267,0.0004612392,0.0006280611,0.0003429038,0.0003218132,0.0001398673,0.000008042412,0.0005427174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003368962,"threshold_uncertainty_score":0.01781696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1261491570014691,"score_gpt":0.3314055627944734,"score_spread":0.2052564057930043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}